scispace - formally typeset
M

Meghan Hufstader

Researcher at University of Tennessee Health Science Center

Publications -  7
Citations -  360

Meghan Hufstader is an academic researcher from University of Tennessee Health Science Center. The author has contributed to research in topics: Health care & Health equity. The author has an hindex of 7, co-authored 7 publications receiving 329 citations. Previous affiliations of Meghan Hufstader include University of Tennessee.

Papers
More filters
Journal ArticleDOI

The comparative burden of mild, moderate and severe Fibromyalgia: results from a cross-sectional survey in the United States

TL;DR: FM imposes a substantial humanistic burden on patients in the United States, and leads to substantial productivity loss, despite treatment, and this burden is higher among subjects with worse FM severity.
Journal ArticleDOI

Cultural competency, race, and skin tone bias among pharmacy, nursing, and medical students: implications for addressing health disparities.

TL;DR: The IAT results indicate that these health care preprofessionals exhibit implicit race and skin tone biases: preferences for Whites versus Blacks and light skin versus dark skin.
Journal ArticleDOI

Societal and individual burden of illness among fibromyalgia patients in France: Association between disease severity and OMERACT core domains

TL;DR: As FM severity level worsened, patients had poorer overall health status and perceived their prescription medications to be less effective, and FM poses a substantial economic and human burden on patients and society.
Journal ArticleDOI

Treatment patterns among physician specialties in the management of fibromyalgia: results of a cross-sectional study in the United States

TL;DR: Pat characteristics were similar across specialties, except with regards to comorbidity burden, and treatment patterns among medications, diagnostics, and outpatient visits did not identify a dominant strategy for FM management.
Journal ArticleDOI

The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors.

TL;DR: The lower use of SSRIs among minorities compared to non-Hispanic whites is associated with lower health expenditures among minorities, and SSRI may be a proxy for improved access to health care due to under-treatment of depression in general.